Calcipotriene Cream, 0.005% And Transparent Dressing
Prescription상품명: Trionex
About This Medication
TRIONEX DESCRIPTION TRIONEX is supplied as 4 components in a kit : -1 TUBE OF CALCIPOTRIENE CREAM 0.005%, 60g (NDC 68462-501-65) - 30 SHEETS OF HYDROFILM TRANSPARENT DRESSING (3 BOXES OF 10 SHEETS)
적응증 및 용법
용량 및 투여 방법
Side Effects Overview
경고 및 주의 사항
WARNINGS FOR EXTERNAL USE ONLY. Avoid contact with eyes, lips or mucous membranes.
금기
CONTRAINDICATIONS Do not use if known hypersensitivity to any of the listed ingredients of any of the components included on the kit.
Frequently Asked Questions
INDICATION AND USAGE Indicated for the treatment of plaque psoriasis.
DOSAGE AND ADMINISTRATION Apply a thin layer of calcipotriene cream to the affected skin 1-2 times daily and rub in gently and completely. The safety and efficacy of calcipotriene cream have been demonstrated in patients treated for eight weeks. Once calcipotriene has been completely rubbed in completely, apply transparent dressing to the affected area as needed as a protectant.
WARNINGS FOR EXTERNAL USE ONLY. Avoid contact with eyes, lips or mucous membranes.
CONTRAINDICATIONS Do not use if known hypersensitivity to any of the listed ingredients of any of the components included on the kit.
Calcipotriene Cream, 0.005% And Transparent Dressing is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Other Products
Browse all Other products →References & Data Sources
- • DailyMed — Calcipotriene Cream, 0.005% And Transparent Dressing drug label (National Library of Medicine)
- • openFDA — Calcipotriene Cream, 0.005% And Transparent Dressing label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 313921 (NLM Normalized Drug Names)
- • NDC Directory — Calcipotriene Cream, 0.005% And Transparent Dressing (FDA National Drug Code)
의료 면책 조항
이 페이지의 정보는 교육 목적으로만 제공되며, 전문적인 의학적 조언, 진단 또는 치료를 대체하는 용도로 사용해서는 안 됩니다.
의학적 상태나 의약품에 관한 질문이 있으시면 반드시 의사 또는 자격을 갖춘 의료 전문가에게 조언을 구하시기 바랍니다.
데이터 출처: DailyMed (NLM), openFDA, MFDS